NDC 45414-311 - Fludarabine Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 45414-311
- Package NDCs from labels
- 45414-311-15, 45414-311-20
- Manufacturer
- Antisoma Research Limited
- Effective date
- 2009-02-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fludarabine Phosphate - Antisoma Research Limited | Antisoma Research Limited | 2009-02-18 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 45414-311-15 | Fludarabine Phosphate | 3 in 1 BOTTLE | TABLET, FILM COATED | 3 | 1 | |
| 45414-311-15 | Fludarabine Phosphate | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 1 | |
| 45414-311-20 | Fludarabine Phosphate | 4 in 1 BOTTLE | TABLET, FILM COATED | 4 | 1 | |
| 45414-311-20 | Fludarabine Phosphate | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fludarabine | FLUDARABINE PHOSPHATE | Fresenius Kabi USA, LLC | cf5255cc-91fd-4132-973b-764dba142eae | 2024-10-14 | Boxed warning, Warnings, Adverse reactions | Fludarabine |
| Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Areva Pharmaceuticals | 8039c2e3-ffe5-3997-e053-2991aa0ad9d0 | 2023-02-14 | Boxed warning, Warnings, Adverse reactions | Fludarabine Phosphate |
| Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Lannett Company, Inc. | 0170c0f4-d502-4f8f-bdbf-6439f3ed33fb | 2023-01-31 | Boxed warning, Warnings, Adverse reactions | Fludarabine Phosphate |
| Fludarabine phosphate | FLUDARABINE PHOSPHATE | Actavis Pharma, Inc. | 3adca34b-4f65-4e21-8058-3c01fc7fc9bb | 2022-09-30 | Boxed warning, Warnings, Adverse reactions | Fludarabine phosphate |
| Fludarabine Phosphate | FLUDARABINE PHOSPHATE | Sagent Pharmaceuticals | 20e5acf0-90b7-45c8-be78-91eaf77c9ac0 | 2021-07-22 | Boxed warning, Warnings, Adverse reactions | Fludarabine Phosphate |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.